SCD1 ablation modifies the protein composition of high-density lipoproteins, reducing the amount of ApoA-I and ApoA-II and increasing the amount of serum amyloid A, which contributes to the development of atherosclerosis [64]. This evidence concerns the gene SCD and atherosclerosis.